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Depression is a significant public health concern with a lifetime prevalence of
24.01 for adolescents in grades 9-12 (Lewinsohn, Hops, Roberts, Seeley, & Andrews,
1993) and a point prevalence of 4-6% (Kessler, Avenevoli, & Ries, 2001). The risks
associated with adolescent onset depression include comorbidity, depressive episodes
continuing into adulthood, and suicidality. These risks make it imperative to develop
effective treatments to address adolescent depression. Stepped care is an approach to
treatment which involves treatment of illness using the least invasive measures first
and moving toward more invasive treatment as indicated by ongoing assessment.
Through a single-participant design, the current study sought to determine the
effectiveness of using a stepped care approach in the treatment of adolescents with
depression using a motivational interviewing assessment (MIA), fun activities (FA),
and values-based behavioral activation (VBBA) phases as treatment steps. Fourteen
participants were subjected to varying levels of the independent variable based on cut
off scores on the Child Depression Rating Scale-Revised (CDRS-R). That is, those
who did not have a clinically robust response following MIA received FA and failure
to respond to FA resulted in participants receiving VBBA. Nine participants
experienced a clinically significant response during one of the three phases of

treatment, while five dropped out of the study. Participants who received behavioral
activation experienced increases on activation measures and decreases on depression
measures following the behavioral activation steps, which provides support for the
behavioral theory of depression.
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INTRODUCTION

The lifetime prevalence of Major Depressive Disorder (MDD) in the United
States has been noted to be 16.2%, while the point prevalence has been estimated at 6.6%
(Kessler et al., 2003) among adults. Depression, however, is also a significant clinical
problem among adolescents. In their survey, Kessler et al. (2003) found that depressive
symptoms appear to rise significantly during the teenage years. In fact, MDD is the most
common psychiatric diagnosis of adolescence with a lifetime prevalence of 24.01 for
individuals in grades 9-12 (Lewinsohn, Hops, Roberts, Seeley, & Andrews, 1993) and a
point prevalence of 4-6% (Kessler, Avenevoli, & Ries, 2001).
The economic cost of depression is a staggering one. Wang, Simon, and Kessler
(2003) noted that depression is one of the most economically burdensome diseases,
impacting the United States by $53 billion annually in 1996. By the year 2000, the World
Health Organization estimated the annual cost to the United States for MDD among all
age groups to have grown to $83 billion (2004). In their survey of participants in the
Treatment for Adolescents with Depression Study (TADS; see below), Domino et al.
(2009) noted that depressed adolescents account for $12 billion of this amount.
While most research on the topic of depression has been related to adults, there is
clear understanding that episodes of adult depression may have an early onset during
adolescence. In fact, one predictor of adult depressive episodes is the experience of
depressive episodes during adolescence (Harrington, 1996; Pine, Cohen, Cohen, and
Brook, 1999). In a community sample survey, Lewinsohn and colleagues (2000)
identified that among individuals who reported experiencing psychiatric difficulties as an
1

adult and who had experienced depression as an adolescent, many tended to have more
severe depressive episodes during adolescence. Even subclinical depressive
symptomotology has been indicated as a predictor of early adult depressive episodes.
Pine et al. (1999) found that many adolescents who presented with subclinical or clinical
depression continued to experience these symptoms throughout adolescence and that
these symptoms were predictive of depressive episodes in early adulthood. These
findings indicate that intervention during adolescence may be both immediately useful as
well as preventative with regard to the recurrence of depression in adulthood.
Comorbidity is also common among those with a MDD diagnosis. Findings from
the TADS group revealed that 51.7% (n = 227) of the sample met diagnostic criteria for
at least one disorder in addition to MDD and 21.4% (n = 94) of the sample met criteria
for three or more disorders beyond MDD (Small, Simons, Yovanoff, Silva, Lewis, et al.,
2008). Consistent with previous findings, this study also reported that among their sample
anxiety disorders were the most common disorders to co-occur with MDD; and, it has
been documented that the rate of co-occuring anxiety disorders may be as much as 26
times higher among depressed adolescents (Angold & Costello, 1993). Further, a metaanalysis of published literature identifying disorders comorbid with MDD indicates that
conduct and oppositional defiant disorders are 3.6-9.5 times higher among adolescents
with a diagnosis of MDD than for those not experiencing depression (Angold & Costello,
1993).
It is widely understood that several factors may be associated with the onset of
adolescent depression. In a longitudinal study, Mazza, Abbott, Fleming, Harachi, Cortes,
Park, et al. (2009) cited family discord, individual characteristics of the adolescent, the
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everyday psychological functioning of the individual, and female gender to be potential
risk factors for depression. Conflict within the family has been implicated to be one of the
most predictive factors with regard to child and adolescent depression (Bond,
Toumbourou, Thomas, Catalano, & Patton, 2005; Seiffge-Krenke, Weidemann, Fentner,
Aegenheister, & Poeblau, 2001). Adolescents who have at least one depressed parent are
also more likely to be depressed themselves (Beardslee, Versage, & Gladstone, 1998;
Field, Diego, & Sanders, 2001; Hammen, Shih, Altman, & Brennan, 2003). Poor
academic performance (Bond et al., 2005) and early peer-related social difficulties
(Reinherz et al., 2000) have also been implicated as risk factors for adolescent
depression. Additionally, as with adult depression, adolescent females appear to be
diagnosed with depression at rates twice as high as adolescent males (Crowe, Ward,
Dunnachie, and Roberts, 2006; Nolen-Hoeksema and Girgus, 1994). While there has
been only speculation as to the reason for a gender-specific difference in rates of
depression, Nolen-Hoeksema and Girgus (1994) argue that girls experience more
difficulties during adolescence than do boys and that these difficulties may moderate risk
factors and subsequent depression.
As the aforementioned risk factors implicate environmental factors in the onset of
depression, these factors may also affect the maintenance of the disorder. Ferster (1973)
and Lewinsohn (1974) proposed a behavioral account for the development and
maintenance of depression. According to this account, depression is maintained as a
result of (a) reinforcement of depressotypic behaviors and (b) a lack of responsecontingent positive reinforcement. Individuals who are depressed tend to engage in
depressotypic behaviors such as crying, not getting out of bed, or making negative self-
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statements in the presence of others. These behaviors tend to be reinforced, for example,
either through help-statements made by others or through escape/avoidance of what are
perceived to be difficult tasks. Alternately, individuals experience anhedonia, or the
failure to experience pleasure in things that the individual used to find reinforcing. Here,
the individual may experience reduced pleasure in hobbies, work, family outings, or other
activities that were once enjoyable.
Treatment of Adolescent Depression
Pharmacotherapy. Three large-scale studies revealed interesting results with
regard to the use of antidepressant medication and psychosocial treatment of MDD
among adolescents. First, the TADS group randomly assigned 439 adolescents to receive
fluoxetine, CBT, combination of fluoxetine plus CBT, or pill placebo (TADS Team,
2004). Study outcomes indicate that during the first 12 weeks of treatment, participants
who received the combination of fluoxetine plus CBT and fluoxetine alone experienced
significant decreases in depressive symptoms, as reflected by dependent measures, than
those who received placebo, while those receiving CBT alone did not. By week 18,
however, those in the CBT alone group experienced similar decreases in depressive
symptoms as those in the combination and fluoxetine groups. A second noteworthy study,
the Adolescent Depression Antidepressant and Psychotherapy Trial (ADAPT),
randomized 208 adolescents to receive an SSRI or SSRI in combination with CBT
(Goodyer, Dubicka, Wilkinson, Kelvin, Roberts, Byford, et al., 2007). Outcomes of the
study revealed no significant outcome advantage for those who received combination
treatment over those who received antidepressant medication alone. Finally, the
Treatment for SSRI-Resistant Depression in Adolescents (TORDIA) study randomly
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assigned 334 adolescents to receive one of two antidepressant medications either with or
without CBT (Brent, Emslie, Clarke, Wagner, Asarnow, Keller, et al., 2008). Results of
the TORDIA study indicate combination treatment was more effective than either
medication treatment alone in decreasing depressive symptoms among adolescents with
medication-resistant depression.
Concern also remains about the use of antidepressant medications, particularly
with children and adolescents, with regard to side effects. In a retrospective survey,
Gualtieri and Johnson (2006) reported findings indicating that 28% (n = 36) of the
participants the study experienced behavioral side effects while taking antidepressant
medications, including suicidal and self-injurious behaviors. In fact, in 2004, the U.S.
Food and Drug Administration issued a black box warning for SSRIs indicating the
potential for suicidal behaviors among adolescents who take the medications. Further,
tricyclic antidepressants have been implicated in sudden cardiac death among children
and adolescents (Geller, Reising, Leonard, Riddle, and Walsh, 1999). In a review of
insurance claim records from 1996 to 2005, Jerrell (2010) found that children and
adolescents who were prescribed SSRIs were more likely to experience significant
weight gain and to be diagnosed with Type 2 diabetes than those children who had not
been prescribed the drugs. Conversely, a survey of 156 adolescents concluded that the
participants hold a preference for psychotherapy over the use of antidepressant
medications (Bradley, McGrath, Brannen, and Bagnell, 2010). Additionally, female
participants reported weight gain and male participants indicated decreased sex drive as
the most adverse side effects of antidepressant medication. Although there remains
concern regarding the use of antidepressant medications among adolescents, there
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continued to be an increase in the number of antidepressant prescriptions made to
adolescents in the United States until the year 2000 (Vitiello, Zuvekas, and Norquist,
2006).
Psychotherapy. Cognitive-behavior therapy (CBT) has been largely recognized as
the treatment of choice for mild to moderate depression based on research demonstrating
its effectiveness and due to fewer side effects than medication treatment. This treatment
involves both a cognitive component, which assists the individual in identifying the
negative thoughts about the self, and a behavioral component, in which the individual is
assigned homework to complete activities that they previously believed they were too
depressed or no longer had interest in doing. In a meta-analysis of research that
implemented Beck’s Cognitive Therapy for depression (CT, but is now recognized as a
CBT; Beck, Rush, Shaw, and Emery, 1979), Dobson (1989) found that CT was more
effective than wait list control, other types of psychotherapy, behavior therapy, and
pharmacotherapy. Since that time, Jacobson and colleagues (1996) conducted a
component analysis of CT in order to delineate the efficacious treatment components and
found that the behavioral component of the treatment (behavioral activation; BA)
performed as well as the treatment component directly targeting automatic thoughts as
well as the full treatment package at decreasing depressive symptoms. Given this finding,
Chambless (1998) recognized BA as a well-established treatment for depression.
Behavioral treatments for depression have evolved since their induction in the
1970’s. Initially, these treatments involved techniques aimed at increasing the
individual’s access to pleasant events and the naturally occurring reinforcers encountered
as a result of engaging in pleasant events, while decreasing aversive consequences (see
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Maintenance of Depression above; see also Hopko, Lejuez, Ruggiero, and Eifert, 2003;
Lewinsohn and Graf, 1973; Lewinsohn, Sullivan, and Grosscup, 1980). As a result of the
behavioral theory of the etiology and maintenance of depression, two behavioral
treatments emerged that have extended beyond the therapist simply assigning pleasant
events in which the client is to engage: behavioral activation (BA; Martell, Addis, and
Jacobson, 2001) and brief behavioral activation to treat depression (BATD; Lejuez,
Hopko, and Hopko, 2001).
Behavioral Activation (BA; Martell, Addis, and Jacobson, 2001). Behavioral
activation is grounded in theory suggesting that aversive control maintains depressive
behaviors. According to Martell and colleagues (2001), depressed individuals engage in
an avoidance pattern that follows a trigger and a negative emotional response. Clients are
taught to recognize this trigger, response, avoidance pattern (TRAP). Once the client
becomes familiar with their own TRAPs, they are taught alternative coping strategies and
to engage in trigger, response, alternative coping (TRAC), which are healthier behaviors
than avoidance patterns. Other techniques used in BA to decrease depressive symptoms
include events scheduling to increase both pleasure and mastery of activities, mental
rehearsal, behavioral rehearsal, and skills training.
Brief Behavioral Activation to Treat Depression (BATD; Lejuez, Hopko, and
Hopko, 2001). The BATD model is grounded in Hernnstein’s matching law (1970;
Hopko et al. 2003). As it applies to depression, the matching law indicates that the
individual’s frequency of behavior will match the reinforcement for that behavior set
forth by the environment. In therapy, clients begin by collecting baseline data with regard
to daily activities. This is followed by identifying their personal values that will later be
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used to assist in developing an activity hierarchy for the client to work through
throughout the course of treatment. A revised version of the BATD treatment manual,
BATD-R, was recently published (Lejuez, Hopko, Acierno, Daughters, and Pagoto,
2011). Updates to the manual include a greater emphasis on values-driven work prior to
activity scheduling, troubleshooting sections, and modified forms to accommodate
individuals with lower reading abilities.
Components of Behavioral Treatments for Depression
While differences among the treatments are clear, Kanter, Manos, Bowe, Baruch,
Busch, and Rusch (2010) identified the common components of these behavioral
treatments for depression. According to the authors, any type of BA involves clearly
delineated assessment, activation, and generalization techniques.
Activity Monitoring. Early on, the therapist presents the client with homework to
keep a daily log of activities along with a rating of the individual’s mood at the time of
the activity. According to Kanter and colleagues (2010), the monitoring of activities is an
ongoing assessment technique that assists both the clinician and client/participant to
identify the relationship between the client’s level and types of activities performed and
the client’s mood. Thus, the client is better able to understand the relationship between
certain types of activities and the way the client feels.
Goals. Prior to prescribing specific activities, the therapist assists the individual to
identify the goals he/she wants to attain. Inherently, the discussion of such goals often
begins with identification of those things that are most important to the individual. The
assessment of personal values, or what is most important to the individual, helps the
client and therapist by developing a road map for selecting activities. Behavioral
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activation for the treatment of depression has made implicit use of personal values to
assist in directing activity scheduling (Lejuez et al., 2003, 2011). Currently unknown,
however, is the extent to which making use of such values-driven assessment and activity
scheduling impacts the outcome of the treatment (Kanter et al., 2010).
Activity Scheduling. Once the current activities and personal values are identified,
specific activities, tied in with personal values, are prescribed for the individual. In a
collaborative manner, the therapist works with the client to identify those activities that
may assist the individual in living a life more consistently with their identified values
(Kanter et al., 2010; Lejuez et al., 2003, 2011).
The Role of Personal Values in a Treatment for Depression
While BATD asserts that the assessment of personal values and their linkage to
activity scheduling are important steps in the treatment, little is known about its
necessity. In the original BATD treatment manual (Lejuez, Hopko, & Hopko, 2002), the
valued life domains identified by Hayes, Strosahl, and Wilson (1999) are used to assist
the client in acknowledging those life areas they find important. In the revised BATD
manual, BATD-R (Lejuez, Hopko, Acierno, Daughters, & Pagoto, 2011), a strong
argument is made for values assessment and scheduling activities directly related to
important life areas. The authors suggest that the selection of activities closely related to
valued life domains helps to ensure that activities will be positively reinforced, whereas,
those activities that are selected arbitrarily are more likely to fail to result in positive
reinforcement. In addition to the BATD-R manual, researchers have used a values-based
approach to behavioral activation with depressed adolescent samples (Gaynor & Harris,
2008). While the assessment and functional use of personal values during event
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scheduling appears to have face validity, the efficacy of such work over that of
scheduling fun activities within the context of treatment for depression is currently
unknown.
BA for Depressed Adolescents
While the use of BA with adult populations has been studied widely, few have
published studies regarding its use with depressed adolescents. In a pilot study, Ritschel,
Ramirez, Jones, and Craighead (2011) adapted BA for use with teens and concluded that
BA is both a feasible and possibly effective treatment for adolescent depression. Their
results indicate that four out of six participants experienced significant decreases in
depressive symptoms related to dependent measures and were within the normal range at
the end of treatment. Gaynor and Harris (2008) also conducted a single-participant study
of BA with depressed adolescents and found that increased levels of activation predicted
decreases in depressive symptoms, whereas changes in thinking patterns did not.
Additionally, McCauley, Schloredt, Gudmundsen, Martell, and Dimidjian (2011)
reported initial findings related to a pilot study of BA for depressed teens. Researchers
reported that 72% of those in the BA group had been independently rated as having
“much or very much improved” (p. 380) compared to 55% of those receiving treatment
as usual. The limited evidence related to pilot studies and single-participant designs
indicates that BA appears to be feasible for use with depressed adolescents and that more
research should be conducted in order to determine its efficacy with this population.
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Treatment Participation and Completion
Study attrition among adolescent treatment outcome research is concerning.
Among privately-insured children and adolescents receiving outpatient mental health
services, 45% remained in treatment less than 30 days (Harpaz-Rotem, Leslie, &
Rosenheck, 2004). Further, participants of the TADS study who were more actionoriented responded more positively to treatment for depression, regardless of the type of
treatment (Lewis, Simons, Silva, Rohde, Small, et al., 2009). Given these findings, efforts
to ensure participants are action-oriented prior to the start of treatment may prove
beneficial.
Motivational Interviewing. Developed out of the work highlighting the
importance of identifying the individual’s current stage of change relative to the difficult
work of treatment, motivational interviewing (MI) involves techniques to help the client
identify their own goals and to reinforce client actions in change-related directions
(Miller & Rollnick, 2002). Previous research has shown MI to have positive effects on
homework compliance and treatment outcome than groups who received the direct
treatment alone (Westra & Dozois, 2006). Lewis et al. (2009) suggest supplementing
depression treatments with techniques to address change ambivalence. Recently, Flynn
(2011) suggested several areas of therapy in which CBT-MI could enhance outcomes
related to treatment for depression: client-therapist relationship development, engaging
the client in treatment, activation, and homework compliance. All of these factors may
mediate treatment outcomes, so it is of great importance to establish strong ties with each.
The use of MI strategies for teens experiencing internalizing, externalizing, family, and
health-related behavior problems has been described and recommended (Naar-King & Suarez,
2011). The important point for the present study is that the MI approach to interviewing and

11

assessment appears applicable to teens presenting with almost any problem. Studies using MI

have reported the techniques to be effective for increasing change-related behaviors
among several populations. In a meta-analysis of MI interventions coupled with behavior
therapy for adolescents, Macgowan and Engle (2010) found that MI techniques have
been implemented across different settings, including schools, other community settings,
and primary care settings. It was also noted that MI techniques, followed by behavior
therapy, has been effective in significantly decreasing substance use among mild to
severe substance using adolescents. MI techniques may also be an effective intervention
for adolescents by increasing medication adherence (Riekert, Borrelli, Bilderback, &
Rand, 2011), increasing safety behaviors among recently injured adolescents seen in an
emergency room (Dunn, Droesch, Johnston, & Rivara, 2004), and healthy behaviors
involving diet and exercise (Olson, Gaffney, Lee, & Starr, 2008). For the present
purposes, the most important finding is that the antidepressant fluoxetine did not add
efficacy to an intervention combining MI and CBT for depressed adolescents (Cornelius
et al., 2009). Moreover, the motivational enhancement complimented CBT group
experienced improvements over a group who had received naturalistic treatment at twoyear follow up (Cornelius et al., 2011). These data speak to the tolerability and possible
efficacy of using both MI and CBT approaches with depressed adolescents.
A Stepped Care Approach to Intervention
Given the concerns regarding medication use among adolescents, as well as the
potential costs related to treatment, a stepped care approach to intervention may be
indicated. Stepped care has been evaluated among medical settings as a preferred
approach to the treatment of physical illness. This type of intervention involves beginning
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treatment with the least invasive treatment option and stepping up to increasingly more
invasive approaches as indicated by the outcome of the prior treatment.
Several phases have been suggested for stepped-care treatment approaches. First,
Broten, Naugle, Kalata, and Gaynor (2010) suggest beginning with self-report measures
and clinical interviews that will inform decision making related to appropriate
interventions. Repeated measures should assist the clinician in determining the
effectiveness of the current intervention and whether or not a higher level of care is
indicated. Second, a watchful waiting period may assist clinicians and clients in
determining if depressive symptoms may remit without direct intervention. In a
comparison of treatment approaches for adolescent depression, Gaynor et al. (2003)
reported that 28% of participants experienced pretreatment improvements. The
researchers also reported that as much as 40% of depressed adolescents may experience
sudden gains, or decreases in depressive symptoms prior to the onset of specific
therapeutic techniques. It has been suggested that a watchful waiting period is useful for
patients as it may be more cost effective, particularly for those who respond early during
treatment, and it is useful for researchers to identify early responders so that these
individuals are not included as part of the participant pool with whom treatment is
evaluated (Broten et al., 2010; Renaud et al., 1998). Watchful waiting periods should last
approximately four weeks, as most pretreatment gains occur within this time frame
(Broten et al, 2010; Gaynor et al, 2003). Third, in a stepped-care model, treatment is to
begin with the most minimal intervention indicated for the individual client (Broten et al.,
2010). Psychoeducation is one type of minimal intervention and involves providing
information to the individual regarding the development and maintenance of depression,
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including symptoms, treatment options, and relapse. Educating individuals about the
specifics related to their disorder is a common practice among most types of
interventions, and particularly within CBT. Outcome data related to the efficacy of
psychoeducation implies that the technique may be useful in decreasing symptoms and
reducing the rates of relapse for depression among adults (Cuijpers, 1998) and among
adolescents when the family receives psychoeducation (Sanford et al., 2006). In addition
to being more cost-effective, Broten et al. (2010) indicate that such minimal interventions
do not require advanced training in the therapeutic techniques. Such interventions may
easily be taught to individuals who have regular contact with adolescents such as
teachers, school nurses, and the like. Next, it is recommended that for individuals who do
not respond positively to minimal interventions, more invasive interventions should be
introduced. According to Broten et al. (2010), these interventions may involve group or
individual therapy and pharmacotherapy. Finally, the most invasive interventions are
introduced when all other types of intervention have failed to lead to decreases in
depressive symptomotology and there is concern for the safety of the individual due to
the risk potential for suicide or other harm. Hospitalization, which is the most invasive
intervention, is the last line approach to treatment for depression for several reasons.
First, inpatient care is costly. In a nationwide review of hospital records collected by the
Healthcare Cost and Utilization Project (HCUP) Kids’ Inpatient Database (KID),
researchers found the cost of one day of inpatient hospitalization for child or adolescent
depression to be about $1,300 (Sclar, Robison, Gavrun, & Skaer, 2008). Second, the
amount of time a child spends in the hospital may be equal to the amount of time the
child is absent from school. Third, there may be stigma involved with psychiatric
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inpatient stays. Finally, recent discharge from a psychiatric inpatient facility has been
indicated as a risk factor for suicide (Jones, 1965; King et al., 2001; McKenzie & Wurr,
2001) and 47% of those who commit suicide following an inpatient stay do so within one
month of discharge (Hunt et al., 2009).
A stepped care approach to the treatment of depression may be amenable to
adolescent patients for several reasons previously indicated. First, although medication
treatment is often an early intervention among prescribing physicians, adolescents prefer
psychotherapeutic techniques due to the side effects produced by medications. Second,
stepped care may be more cost effective than other approaches as it requires the
consideration of less invasive techniques prior to those that are more invasive and costly.
Additionally, the least invasive techniques may be administered by less specialized care
providers, which may also be more cost effective. And finally, hospitalization is the last
consideration in this approach. This saves money as hospitalization is costly and may
serve as a risk factor for suicide, particularly following recent discharge.
Statement of Purpose
Given that adolescent depression is a major public health concern with
implications for the recurrence of episodes into adulthood, there is a need to develop
effective treatments to address the disorder. The current study sought to determine the
effectiveness of implementing motivational interviewing assessment (MIA) prior to
behavior therapy in order to attempt to increase the motivation of participants, increase
retention, and increase homework compliance.
Further, the current study sought to determine the utility of presenting a stepped
care approach to the treatment of adolescent depression. Participants were presented with
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MIA, followed Fun Activities (FA) for those who did not respond to MIA, followed by
Values-Based Behavioral Activation (VBBA) for those who did not respond to FA.
Finally, the usefulness of an explicit values component added to behavior therapy
is currently unknown. This study sought to determine the utility of an added values
component affects outcomes when treating adolescent depression.
METHODOLOGY
Participants
A total of 14 adolescents ages 13-18 were recruited from two local high schools to
participate in the study (Appendix B). Participants were recruited without regard to race,
sex, socio-economic status or ethnicity. All study related meetings with the participant
and his/her guardian took place at the relevant school, with the exception of three
meetings that took place at the participant’s homes due to transportation difficulties or
family preference.
Once the student investigator was contacted by a potential participant’s caregiver
or school counselor after receiving parental consent, an appointment was scheduled to
conduct informed consent/assent and the initial screening. Participants were eligible for
study inclusion if they were identified as experiencing clinically significant distress, as
indicated by a score of 45 or higher on the Children’s Depression Rating Scale-Revised
(CDRS-R; Proznanski and Mokros, 1996). This cutoff score was used in the NIMHsponsored TADS trial previously mentioned (TADS, 2004), which involved the largest
adolescent depression treatment study ever conducted. All potential participants met
inclusion criteria by meeting the CDRS-R inclusionary cutoff and by not endorsing
psychotropic medication changes within the eight weeks prior to screening. Following
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screening and study inclusion, all participants were asked to begin the MIA phase of
treatment. Given the wide applicability of MI as a style of communicating with teens
(Naar-King & Suarez, 2011), there were no exclusion criteria for entering the MIA phase.
Measures given during MIA phase revealed diagnoses that served as exclusionary criteria
for progressing to FA. Participants were to be excluded from study participation
following MIA if they were prescribed antidepressant medication and have been taking
the medication for less than eight weeks, a current diagnosis of bipolar disorder,
psychotic disorder, pervasive developmental disorder, conduct disorder, anorexia
nervosa, obsessive compulsive disorder, autism, or alcohol or drug dependence
(excluding caffeine and nicotine). Potential participants were not excluded based on the
presence of suicidal ideation, as this is one diagnostic criterion for depression. However,
such participants were assessed for the presence of a suicide plan, intent to die, and
access to means. No participants indicated the presence of the intent to die during this
study.
The caregiver, child, and the study therapist were present at the beginning of the
meeting, which began with a verbal explanation of the study. This explanation was
guided by the consent document and was conducted verbally by the researcher. All
details included in the consent form were summarized and any questions the participant
or guardian had were answered. Caregivers and participants were encouraged to read the
consent document prior to signing and to ask any unanswered questions. After both the
caregiver and participant provided consent, the caregiver was asked to leave the room to
complete a demographic questionnaire. All participants and at least one of their legal
guardians provided written informed consent prior to the participant engaging in any
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study-related activity.
Once consent and assent documents were thoroughly reviewed and signed,
participants were assessed for qualification for inclusion. Inclusion criteria for the MIA
phase were age of 13- 18 years and a CDRS-R score of 45 or higher at the time of
consent. Those who failed to meet inclusion criteria, meet exclusion criteria, or decide to
discontinue participation following MIA were to be referred for additional services
within the community, however, all potential participants met initial inclusion criteria and
were asked to continue into the MIA phase.
Design
A single participant A/B/C design was utilized where exposure to the next level of
the independent variable in the sequence is based on treatment response at the prior level
(see Appendix A). That is, a clinically significant response to A precluded exposure to B.
Specifically, those participants who experienced a decrease in depressive symptoms
below the depressive cutoff during MIA were deemed to fail to meet the inclusion
criterion (CDRS-R score ≥ 45) for continuance into the active treatment. In the current
study, MIA was conceptualized as a minimal intervention, rather than a watchful waiting
period. In clinical settings, clients typically attend several sessions prior to the receipt of
an active treatment. The current study attempted to mimic the flow of treatment found
within clinical settings. Following FA, those who experienced a clinically significant
change received one session of FA Booster, while those who did not experience a
clinically significant change following FA were asked to continue on to VBBA.
Following FA Booster, or VBBA, whichever applied, participants who wished to receive
further services were provided with a list of local providers. Multiple measures were
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taken throughout the course of the study in order to determine treatment effects and
ensure that change occurred at a reasonable time in the treatment protocol. This protocol
involved a stepped-care approach which mimics increasing levels of care that may be
recommended in practice settings.
Informed Consent
Since youth under the age of legal consent were recruited for the study, a consent
document for the legal guardian and a document of child assent were created that
included the name program, names of the principle and student investigators, the project
title, and a detailed explanation of the rights of the child. A flow chart to accompany the
consent form was developed to help consenting caregivers and participants track the
possible courses of care more readily (Appendix A). As the study also included
participants who are of the legal age to consent (those who are 18 years of age), a consent
document was also created for those potential participants to sign without parental
consent. These rights include a simple description of the study, the right to withdraw/not
participate, information regarding their role in the experiment including risks and
benefits, the right to access the results and of confidentiality. Permission to videotape the
sessions is also included with contact information for the investigators. Additionally, the
parental consent document included method of dissemination, explanation of the tests and
measures, description of data collection, confidentiality, storage, and HSIRB contact
information. An explanation was given informing the parent that they have the right to
withdraw their child at any point during the experiment with no negative effects on them
or their child.
Measures
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Demographic measure. This measure has been developed by the researcher and is
meant to gather information related to the background characteristics of each participant
including age, sex, race, and grade in school.
Mini International Neuropsychiatric Interview for Children and Adolescents
(MINI-KID; Sheehan et al., 2010). This is a screening instrument and follow up
diagnostic interview appropriate for children and adolescents that was used to screen for
depression and other DSM-IV-R diagnoses (kappa = 0.56-0.87 for mood disorders).
Based on scores obtained, diagnostic cutoffs were used to identify those individuals who
were experiencing major depression, minor depression, subclinical depression, and those
who are not depressed. The MINI-KID consists of a screening measure and follow up
interviews based on the indication of the possible presence of a disorder per scores
obtained through the screening measure. All follow up interviews were administered as
were indicated ideographically by the screening measure with all participants.
As the interviews are idiographic based on the screening measure, the length of
administration varies (M = 33 ± 14 minutes). Therefore, the screening tool was
administered during pre-screening and the interviews were administered during the final
session of the MIA phase. The depression interview was administered with all
participants regardless of screening score.
Children’s Depression Rating Scale-Revised (CDRS-R; Proznanski & Mokros,
1996). This semi-structured interview was used as the primary dependent variable. A
score of 40 or higher is indicative of depressive disorder. The CDRS-R was initially
developed for children, but has shown good to excellent internal consistency (α = .74 -
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.92) when used to measure depression among adolescents (Mayes, Bernstein, Haley,
Kennard, and Emslie, 2010). The CDRS-R was administered at each assessment session.
Twenty percent (n = 9) of the 45 CDRS-R interviews were also coded by an
independent rater, who was trained on practice tapes to reliability and had experience
administering the CDRS-R in a similar setting. Intra-class correlation across all items was
ICC = .89 (n = 153, p = .00), indicating significant reliability between raters among
measure items. As the CDRS-R total was the dependent measure that determined the
participant’s next step (either into the next study phase or out of study treatment), the
independent rater’s scores were examined to see if they resulted in the same decisions as
those of the study therapist (i.e., whether or not the participant experienced a clinically
significant change). There was 100% agreement in clinically significant change between
the therapist and coder.
Multigroup Ethnic Identity Measure (MEIM; Phinney, 1992). The MEIM is a 14item measure on a four-point Likert scale that is used to determine the ethnic group with
which participants personally identify. This measure was used in order to most accurately
characterize the cultural identification of participants and to examine correlates between
treatment outcome and ethnicity. The MEIM has good internal consistency (Cronbach’s
α = .81) when administered to high school students (Goodstein & Ponterotto, 1997).
MEIM was administered at pretreatment assessment.
MacArthur Scale of Subjective Social Status-Youth Version (MSSSS; Goodman,
Adler, Kawachi, Frazier, Huang, & Colditz, 2001). This 1-item measure was used to
characterize the perceived socioeconomic status of the participants. The MSSSS asks the
respondent to indicate where his/her family stands on a ladder. The rungs on the ladder
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correspond to common SES indicators; that is, the top rung represents those with the
most money, education, and prestigious jobs and the bottom rung represents those with
the least money, education, and employment prestige. The scale shows good reliability at
.73-.79. MSSSS was administered at pretreatment assessment.
Stages of Change Questionnaire (SOCQ; McConnaughy, Prochaska, & Velicer,
1983). This 32-item measure identifies the participant’s current level of motivation for
change, which is indicative of the effort the individual is likely to put forth for such
change to occur. The measure has good reliability (Cronbach’s α = .88 - .89) on each of
four subscales. The SOCQ was used by Lewis et al. (2009) to determine the association
of the particular stage of change with scores on depression measures among adolescents
participating in the TADS study. Item factors were found to account for 56% of the
variance along four subscales: precontemplation, contemplation, action, and maintenance.
This measure was administered at pre-treatment, A2, A3, A4, and A5.
Behavioral Activation for Depression Scale-Short Form (BADS-SF; Manos,
Kanter, & Luo, 2011). A nine-item shorter version of the BADS was administered to the
adolescents at each therapy and assessment session. This measure provides a total score,
with higher scores indicative of higher activation. Scores range from 0-54 through a
seven-point Likert scale. BADS-SF has shown good internal consistency (α = .819).
Beck Depression Inventory –II (BDI-II; Beck, Steer, & Brown, 1996). The BDIII is a 21-item self report measure related to symptoms of depression. Ranges for
interpretation have been recommended as follows: 0 to 9 = non-depressed; 10 to 15 =
mild depression; 16 to 23 = moderate depression; and ≥ 24 = severe depression (Roberts,
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Lewinsohn, & Seeley, 1991; Appendix I). BDI-II was administered at each assessment
point.
Beck Depression Inventory –Short Form (BDI-SF; Beck & Beck, 1972). This 13item measure is an abbreviated version of the BDI. The BDI-SF has samples from the
negative self-attitude, performance difficulty, and somatic symptoms factors of the BDI
as they have been found to have discriminant validity (Bennet et al., 1997). A cut off
score of 9 is recommended as it has been found to maximize specificity and sensitivity.
BDI-SF was administered as a repeated measure at each therapy session.
Therapist Alliance Scale for Adolescents (TASA; Shirk, 2003). TASA is a 12item measure, scaled on a six-point Likert, of therapeutic alliance and is administered to
the participant. The measure has good internal consistency (α = .86). This measure was
administered at the assessment sessions following MIA, FA, and VBBA.
Procedure
Screening. Potential participants were referred to the study therapist by the school
counselor or Communities in Schools representative. Either the school representative or
the study therapist scheduled a time to meet with the potential participant and a guardian
to begin the informed consent process. During the initial appointment, participants and
their parent or guardian were informed of the study and presented with the informed
assent and consent documents, respectively. Once informed consent/assent was obtained,
participants were asked to complete the CDRS-R as a pre-screening assessment for the
study. Participants who scored at or above 45 on the CDRS-R were to be eligible for
further assessment and potential inclusion in the study.
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Once an adolescent agreed to participate and the legal guardian consented, and the
CDRS-R has been administered, further assessment took place. The measures
administered during screening include: Demographic measure, CDRS-R, MEIM,
MSSSS, SOCQ, BDI-II, BADS-SF, and MINI-KID.
Motivational Interviewing Assessment. Once screening was concluded,
participants entered the MIA phase in which they received up to three weekly sessions of
Motivational Interviewing Assessment (MIA) with the therapist over a four week period.
Post-MIA evaluation occurred four weeks following the screening, which was enough
time to allow for three sessions of MIA to occur between assessment points.
The MIA strategy was guided by a publically available training manual; that is,
Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency
(MIA: STEP; Martino, Gallon, Hall, et al., 2006). In short, the manual provides a
“sandwich” approach to interviewing when structured assessments (in this case MINIKID) are sandwiched between MI-style discussions. Each of the three possible MIA
sessions used this approach. Once the MINI-KID interviews were complete, the sessions
took on an MI-style discussion. The therapist began each MIA session by administering
the BADS-SF and BDI-SF. During the first three possible MIA sessions, the therapist
spent approximately the first 1/3 of the session engaging the participant in a MI-style
discussion of the participant’s motivation for change. This was followed by
approximately 1/3 of the session spent engaging the participant in MINI-KID follow up
interviews. Finally, the therapist completed the remaining 1/3 of the session with MIstyle discussion of the participant’s motivation for change as well as discussion structured
to build rapport and gain information from the participant related to their own perception
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of the problems he or she was experiencing, and reinforce occurrences of change talk on
the part of the participant.
During the fourth session of MIA, participants were asked to participate complete
the following measures: CDRS-R, SOCQ, BDI-II, BADS-SF, and TASA. Participants
who experienced a decrease in depressive symptoms as evidenced by both (a) an 11 point
decrease in CDRS-R scores and (b) a total CDRS-R score ≤ 37 were discontinued from
treatment and scheduled for a follow up assessment to take place six weeks later. Those
who did not experience this clinically significant response were asked to continue into
Fun Activities.
Fun Activities. Behavior therapy consisted of up to four sessions of fun activities
(FA) adapted from the STEADY manual (Clarke, DeBar, Ludman, Asarnow, & Jaycox,
2002). The STEADY manual consists of 9+ sessions divided between cognitive
restructuring and behavioral activation (fun activities). The current study used fun
activities materials borrowed from the STEADY manual. During the FA phase,
participants received psychoeducation related to depression, discussion of fun activities,
and assignment of fun activities and mood diaries to complete between sessions. Prior to
each session, the therapist administered the BADS-SF and BDI-SF. Assessment
following FA took place six weeks following the final session of MIA, which allowed
time for participants to receive up to four FA sessions.
Post-Fun Activities Assessment. Six weeks following the final MIA session,
participants were asked to complete Post-Fun Activities Assessment measures. This
session consisted of administration of CDRS-R, SOCQ, BDI-II, BADS-SF, and TASA.
Again, participants who experienced a clinically significant decrease in depressive
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symptoms were discontinued from treatment and scheduled for a follow up assessment to
take place six weeks later. Those who did not experience a response to treatment were
asked to continue into values-based behavioral activation.
Values-Based Behavioral Activation. Values-based behavioral activation (VBBA)
consisted of up to four sessions of treatment. The protocol for this phase of treatment was
adapted from the Gaynor and Harris (2008) manual. Psychoeducation was provided
related to activities of importance and the participant’s own personal values were
assessed. Values-based activities were scheduled for the participant to complete based on
the assessment and in collaboration with the participant through values clarification
exercises. Prior to each session, BADS-SF and BDI-SF were administered. Assessment
following VBBA was scheduled six weeks following post-FA assessment. Assessment
was linked to time rather than the number of sessions the participant has received.
Post-Values-Based Behavioral Activation Assessment and Follow Up. Six weeks
following post-FA assessment, participants were asked to complete the post-VBBA
assessment. Once again four weeks following post-VBBA assessment, participants were
asked to complete the follow up assessment. Both of these assessment points consisted of
participants being asked to complete the CDRS-R, SOCQ, BDI-II, BADS-SF, and TASA.

Treatment Integrity
The study therapist completed a measure of treatment adherence following each
therapy session. Items on the adherence measure were derived from similar items used by
Gaynor and Harris (2008) in a study of treatment for adolescent depression and were
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scored on a 1 (not at all) to 6 (entirely) Likert scale. Twenty-five percent (n = 14; 8 MIA,
5 FA, and 1 VBBA) of sessions were also coded by a trained doctoral student and were
selected quasi-randomly to ensure adequate distribution of participant recordings and
treatment phases. Those sessions coded by both the therapist and the independent coder
indicated significant agreement for MIA items (n=168, r=.98, p=.00), FA items (n=105,
r=.96, p=.00), and VBBA items (n=21, r=.99, p=.00). An intraclass correlation also
showed high therapist and coder agreement (n = 294, ICC = .953, p = .00).
Treatment adherence was defined as the extent to which the therapist applied the
treatment as indicated by the protocol. Not all sessions contributed to all items, therefore,
adherence scores were calculated for items during relevant sessions, according to the
protocol for each phase. For MIA, depending on the session, items rated were: Did the
therapist provide a sensible treatment rationale in a clear manner? (Session 1); Did the
therapist check the participant’s understanding of the treatment rationale? (Session 1); To
what extent was the therapist’s behavior mainly directed toward attempts to understand
the participant's life difficulties and/or ambivalence toward treatment? (Sessions 1, 2, and
3); To what extent was the session’s content focused primarily on the client’s
feelings/emotions (as opposed to skill acquisition or activity scheduling)? (Sessions 1, 2,
and 3); To what extent did the therapist use OARS (open-ended questions, affirmations,
reflection, summarize)? (Sessions 1, 2, and 3); and, To what extend did the therapist
make use of the Decisional Balance worksheet (introduce the worksheet, complete the
worksheet, refer to the worksheet)? (Sessions 1, 2, or 3). MIA adherence (n = 36)
averaged 5.69 (.96) for the study therapist and 5.84 (.49) for the coder.
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Items rated for FA were: Did the therapist provide a sensible treatment rationale
in a clear manner? (Session 1); Did the therapist check the participant’s understanding of
the treatment rationale? (Session 1); Did the therapist review the client’s homework from
the previous session? (Sessions 2, 3, and 4); Did the therapist explain and assign the
homework (Fun Activities, Values-Based Activities) for the next session? (Sessions 1, 2,
and 3); Did the therapist make use of the Mood Diary by explaining its use? (Session 1);
Did the therapist assign the Mood Diary for homework? (Sessions 1, 2, and 3); Did the
therapist explain the association between thoughts, feelings, and behavior? (Sessions 1
and 2); Did the therapist explain both upward and downward spirals? (Session 1); Did the
therapist assist the participant in selecting fun activities? (Sessions 2 and 3); Did the
therapist assist the participant in selecting mood and activity goals? (Sessions 3 and 4);
Did the therapist review the participant's progress toward mood and activity goals?
(Session 4); Did the therapist make use of the Daily Activity Log by explaining its use?
(Session 1, 2, or 3); Did the therapist assign the Daily Activity Log for homework?
(Session 1, 2, and/or 3). FA adherence ratings were (n = 37, M = 5.8, SD = .83) for the
study therapist and (n = 35, M = 5.93, SD = .93) for the coder. The difference between
the number of items coded by the therapist and the coder are due to video recording
difficulties that did not allow the coder to view the entirety of one session selected for
coding.
Based on the quasi-random selection of session recordings for treatment
adherence coding, only one session of VBBA was selected. For VBBA session 2, the
following items contributed to adherence ratings: Did the therapist provide a sensible
treatment rationale in a clear manner?; Did the therapist check the participant’s
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understanding of the treatment rationale?; Did the therapist review the client’s homework
from the previous session?; Did the therapist explain and assign the homework (Fun
Activities, Values-Based Activities) for the next session?; Did the therapist administer the
values assessment?; Did the therapist clearly define values?; and, Did the therapist assign
the 20 things chart? Adherence ratings for the VBBA session were (n = 7, M = 5.71) for
the therapist and (n = 7, M = 5.71) for the independent coder.

RESULTS
Sample Characteristics
Fourteen participants ages 14-18 (M = 15.71) were recruited and provided
consent/assent to participate in the study (see Table 1). Participants were students in
grades 9-12 (M = 10.29) and were recruited through two high schools. The study sample
self-reported as a diverse group of participants; 28.6% Euro-American, 42.9% African
American, 14.3% Latino, and 14.3% Biracial. Normative data for the MSSSS community
ladder showed a mean of 7.2 ± 1.3 (Goodman et al., 2001). Average self-report of
socioeconomic status as indicated via the MSSSS for the current sample was 4.93 (SD =
2.20). Responses ranged from 1-10 with 1 = “people who are worst off” and 10 = “people
who are the best off.” Upon caregiver report, 50% indicated a household income of
$5,000 – 24,999 annually, and 50% reported an income of $25,000 – 74,999. Fifty-seven
percent (n = 8) of participants were reported to live in a single-parent home and in 57%
of cases, it was reported that the biological mother had a history of depression.

29

30

10 African American No
12 Biracial
10 African American No
11 Caucasian
9 African American No
9 African American No
12 African American Yes
9 Latino

Female 15
Female 17
Female 15
Female 16
14
14

15
16
15

Male
Female 17
14

Male

Male
Male
Male
Male

4

5

6

7

8

9

10

11

12

13

14

Yes

Yes

No

No

Yes

No

No

1st Degree (mother)

None

MDD, Anxiety

MDD

MDD, Anxiety

MDD, Anxiety

MDD

None

MDD, SA, CD

MDD, ADHD

MDD, Anxiety

MDD

MDD, ODD

1st Degree (mother)

Aunt

None

1st Degree (mother)

None

None

None

1st Degree (mother)

None

1st Degree (mother)

1st Degree (mother)

1st Degree (mother)

MDD, ADHD, ODD 1st Degree (mother)

MDD

of Depression

Family History

Note: MDD = Major Depressive Disorder; ADHD = Attention Deficit Hyperactivity Disorder; ODD = Oppositional Defiant Disorder; SA =
Substance Abuse; CD = Conduct Disorder

9 Latino

10 Caucasian

9 Biracial

12 Caucasian

18

Male

3

Yes

11 Caucasian

Female 17

11 African American Yes

2

17

MINI-KID

2 caregivers Diagnoses

Live with

Male

Age Grade Ethnicity

1

Participant Sex

Table 1. Demographic and Clinical Characteristics

Measures administered during Assessment 1 (A1) indicated that participants were
significantly depressed. CDRS-R scores at A1 ranged from 47 to 79 with a mean (SD) of
58.79 (9.11). A CDRS-R score ≥ 45was required for inclusion (following TADS, 2004)
and a score of ≥ 40 is generally accepted as indicative of probable major depressive
disorder (MDD), while a score of ≤ 28 has been used as a cutoff for remission (Mayes,
Bernstein, Haley, et al., 2010). Ranging from 3-44, the mean (SD) BDI-II score at
screening was 21 (11.48), a score suggestive of moderate depression. BADS-SF scores at
screening were indicative of lower levels of activation with a range of 11-35 and M =
22.57 (7.24). BADS-SF scale scores range from 0-54 with higher scores indicative of
more activation and a normative mean of 25.68 (8.21) in a sample of undergraduates who
felt sad, down, or blue (Manos, Kanter, & Luo, 2011). According to their HRQOL
responses, participants also reported having poor mental health on 43% of the 30 days
prior to screening with a mean (SD) of 13.43 (8.85) and a range of responses from 0-28.
Diagnostic status was determined via the MINI-KID conducted during MIA.
Results of MINI-KID interviews indicate 12/14 (86%) participants met criteria for MDD.
In 8/12 (67%) cases, participants also met criteria for at least one comorbid diagnosis
including anxiety (n = 4) and disruptive behavior disorder (n = 4) (see Table 1).
Sample Outcomes
Of the fourteen participants recruited for the study, fourteen entered the MIA
phase and were considered part of the intent-to-treat sample. Participants were considered
to have a clinically significant change on the CDRS-R, the primary dependent measure, if
their score decreased by > 11 points (reliable change index) resulting in a total score of
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< 37 (placing the participant within 1 SD of the normative range on the CDRS-R). These
values were determined a priori to capture a magnitude of change that was beyond what
might be expected by sampling variation alone on the CDRS-R that resulted in
functioning that approximated that expected among normative group. Nine of the
fourteen participants (64%) met CDRS-R criteria for clinically significant change at some
point during the stepped-care protocol. Five participants (35.7%) had a clinically
significant change during MIA as indicated by their A2 CDRS-R scores and were
stepped out of additional treatment and assessed again at A5, while two (14%) dropped
out during MIA. Seven participants continued into the FA phase. Three participants
(42.9% of those entered into FA) dropped out of FA, while three (42.9% of those entered
into FA) showed clinically significant change at A3 and were stepped out of additional
treatment. The one remaining participant who entered FA failed to show significant
change and was entered into the VBBA phase. The participant who entered VBBA
showed clinically significant improvement at A4 on the CDRS-R. Thus, of the 64% who
had a clinically significant response on the CDRS-R, 36% responded to MIA and were
stepped out of treatment, 21% responded to FA and were stepped out of treatment, and
7% responded to VBBA. The remaining 36% dropped out during the stepped care
protocol. Figure 1 shows the flow of participants through each phase of the study and
Table 2 shows attendance for each participant.
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Assessed for eligibility (n=14)

Excluded (n= 0)
♦ Not meeting inclusion criteria
(n=0)
♦ Declined to participate (n=0)
♦ Other reasons (n=0)
Included (n=14)

Allocated to MIA (n=14)
♦ Received 1-3 sessions of
MIA (n=14)
♦ Did not receive 1 session
of MIA (n=0)

Allocated to FA (n=7)
♦ Received 1-4 sessions
of FA (n=7)
♦ Did not receive 1
session of FA (n=0)

Allocated to VBBA (n=1)
♦ Received 1-4 sessions of
VBBA (n=1)
♦ Did not receive 1 session
of VBBA (n=0)

Discontinued MIA
(declined to continue)
(n=2)

Discontinued FA (declined
to continue) (n=3)

Discontinued VBBA (declined
to continue) (n=0)

Responded during FA
(CDRS-R) (n=3)

Responded during VBBA
(CDRS-R) (n=1)

Responded during MIA
(CDRS-R) (n=5)

Did not respond during
MIA (CDRS-R) (n=7)

Did not respond during FA
(CDRS-R) (n=1)

Figure 1. Participant Flow Diagram
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Did not respond during VBBA
(CDRS-R) (n=0)
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X

X

X

X

MIA Drop out

FA

FA Drop out

MIA Drop out

11

12

13

14

X

MIA

8

X

X

MIA

7

MIA

X

MIA

6

10

X

FA

5

X

X

FA Drop out

4

MIA

X

FA

3

9

X

VBBA

2

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

FA Drop out

MIA

1

A1
1

Responder

Status

Part

X

X

X

X

X

X

X

X

X

X

X

2

MIA

X

X

X

X

X

X

X

X

3

MIA

Table 2. Responder Status and Attendance

X

X

X

X

X

X

X

X

X

X

X

X

X

X

A2

X

X

X

X

X

X

X

1

FA

X

X

X

X

X

2

FA

X

X

X

3

FA

X

X

X

X

4

FA

X

X

X

X

X

A3

X

1

VBBA

X

2

VBBA
3

VBBA

X

4

VBBA

X

X

X

X

X

A4

X

X

X

X

X

X

X

A5

As noted previously, 36% of the sample had a clinically significant response to
MIA. One way ANOVAs were conducted in order to explore A1 differences between
those who responded to MIA and those who did not (including those who either
responded to FA or VBBA or dropped out of the study). A significant difference (F 1, 13 =
4.57, p = .05) was found between CDRS-R scores for MIA responders [M = 52.60 (4.56)]
at A1 and those who did not have a significant response to MIA [M = 62.22 (9.34)].
Similarly, participants who responded to MIA [M = 12.8 (6.38)] reported fewer
depressive symptoms on the BDI-II (F1, 13 = 5.28 p = .04) at A1 than other participants
[M = 25.56 (11.33)]. Interestingly, 4/5 who had a clinically significant change during
MIA were also 4/5 participants (6, 8, 9, & 10) who had no family history of depression in
a first degree relative (Fisher’s Exact Test, p = .02). In addition, those responding to MIA
[M = 28.00 (5.79)] also reported higher activation (F 1, 13 = 6.03 p = .03) at baseline than
later treatment responders and those who dropped out of the study [M = 19.67 (6.23)].
MIA responders [M = 7.80 (5.45)] did not report having less difficulty as a result of poor
mental health as indicated through the HRQOL than other participants [M = 16.56
(9.03)], although the trend was nearing significance (F 1, 13 = 3.84, p = .07). Finally, those
responding to MIA [M = 65 (7.35)] were not significantly different than other groups [M
= 60.88 (8.74)] with regard to therapeutic alliance, as measured by the TASA at A2,
following the receipt of MIA (F 1, 13 = .767, p = .40). Thus, alliance does not appear a
plausible explanation for those who had a clinically significant change in MIA, instead it
appears that those who responded to MIA were less severely depressed, had a less
significant family history of depression and were more activated prior to the start of
treatment.
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Tables 3-11 include participant scores on measures taken at assessment points
throughout the study and are grouped by responder status. Means and standard deviations
are included in the tables. Reliable change indices (RCI) were calculated for outcome and
process measures in order to determine the changes in scores necessary to identify that
which is beyond what would be expected as a result of measurement error. The asterisks
in Tables 3-5 and 7-11 indicate where participants met the RCI. Reliable change was not
calculated for HRQOL as no normative data for this single-item measure is available. The
CDRS-R was the main dependent measure for the current study and the cutoff was based
on an a priori RCI criterion of ≥ 11-point change (Poznanski & Mokros, 1996). Step
progression; however, was not determined solely by the RCI. Participants were stepped
out of the protocol if they met the RCI and had a total CDRS-R score of < 37. When both
criteria were met, the participant was considered to have had a clinically significant
change; that is, a clinical response that was large in magnitude and placed him/her within
1 SD of the normative mean on the CDRS-R. The asterisks in Table 3 represent only the
RCI. As indicated in Table 3, 9/14 (64%) met the RCI criterion from A1 to A2, which
was the assessment point immediately following MIA. One participant (7%) experienced
a reliable worsening of symptoms during the interval containing MIA. Four participants
who were stepped into and completed FA met the RCI at A3, while the participant (P1)
who dropped out after 1 FA session showed a reliable worsening of symptoms at A3. Of
note, 3/4 who met the RCI during the FA interval also had an RCI during MIA. The
combined effect resulted in these 3 participants having CDRS-R scores indicative of
clinically significant change at A3. The participant who had a reliable worsening during
MIA had an RCI during FA that represented a return to the pretreatment level on the
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CDRS-R. This participant was stepped into VBBA during which change that satisfied the
RCI was achieved that also resulted in meeting the threshold for clinically significant
change.
Psychometric evaluation of the BDI-II with both adult and adolescent outpatient
populations has yielded a Cronbach’s alpha of .92 (Beck et al., 1996; Steer et al., 1998).
Using Cronbach’s alpha as the measure of reliability and the standard deviation from the
current sample at A1 (11.48), yielded an RCI of 9 for BDI-II. Table 4 shows the mean
(SD) on the BDI-II for each participant, with an asterisk indicating the RCI was met.
Three of five (60%) of those who had a clinically significant CDRS-R change during
MIA met the BDI-II RCI criterion at A2; however, as previously mentioned, MIA
responders had significantly lower A1 BDI-II scores than other participants so that the
RCI was more difficult to achieve, which was particularly apparent for P6. Of the four
participants who completed FA, two met reliable change following MIA and 1 following
FA. Participant 12, who did not reach the RCI, had a relatively low A1 BDI-II score of 16
and a score of 9 at A2. P5 met the reliable change criterion at A2, and reached the
criterion again at A3, following receipt of FA. As the BDI-II score for P3 at A2 decreased
to 7, it was impossible for the participant to meet the criterion at A3. Finally, P2 did not
meet RCI following MIA or FA but was identified on the CDRS-R as having a clinically
significant VBBA response and achieved the RCI at A4, following receipt of VBBA.
The RCI for BADS-SF was calculated using psychometric data, specifically
Cronbach’s alpha of .82, reported in Manos, Kanter, and Luo (2011) and the standard
deviation of the current sample (SD = 7.16) at A1 to yield a RCI of 8.44. Overall, 2/14
(14%) participants demonstrated reliable change on the BADS-SF during the A1-A2
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interval. One of five participants who had a clinically significant change during MIA
(P10) achieved the RCI at A2. Of those who participated in FA, 2/4 met the RCI during
FA (P5 and P12), including 2/3 of those who had a clinically significant response on the
CDRS-R during FA. Interestingly, the third participant (P3), while not meeting the RCI
criterion during the A2-A3 interval, did show change from A1-A3 such that the
cumulative effect exceeded the RCI. Finally, the participant who had a clinically
significant CDRS-R response to VBBA also met the RCI on the BADS-SF during the
A3-A4 assessment interval. Thus, of the 4 participants who demonstrated a clinically
significant change during either of the two behavior therapy steps, 3/4 showed reliable
change on the BADS-SF during that same assessment interval, while 1/4 did not exceed
the RCI criterion during the A2-A3 interval but the accumulated change from A1-A3 did.
These findings suggest that while MIA likely took advantage of participants with less
severe depressive symptoms and higher baseline activation levels, it was not particularly
associated with increased activation. On the other hand, response to behavior therapy was
consistent with the theory of therapeutic change wherein activation treatment produces
reliable increases in client activation in his/her environment resulting in decreased
depressive symptoms.
SOCQ subscale reliable change criteria were calculated using reliability data
reported by Lewis et al. (2009) and the standard deviations from the current sample at
A1. Based on Cronbach’s alpha of .80 and a standard deviation of 4.44 for the total
sample, the precontemplation RCI was calculated to be 5.50. Of the participants who
entered MIA, 2/14 (14%) showed a reliable decrease in precontemplation during MIA.
One of fourteen (7%) showed a reliable increase during MIA and one participant showed
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a reliable increase on precontemplation over the follow up period. The contemplation
subscale RCI was determined to be 3.84 based on Cronbach’s alpha of .75 and standard
deviation of 2.77. Three of fourteen (21%) participants showed a reliable increase in
contemplation during MIA. One of four (25%) participants who entered FA showed a
reliable decrease in contemplation at A3, which immediately followed the FA phase. Two
of four participants (50%) who received FA experienced a reliable change increase in
contemplation at A4, which was a follow up session for those participants, one of which
(P12) returned to the near baseline contemplation score. Reliable change of 4.86 on the
action subscale was derived from Cronbach’s alpha of .76 and the current sample
standard deviation of 3.58. Three of fourteen (21%) participants showed a reliable
decrease in action scores following MIA. One of four (25%) participants who received
FA experienced a reliable change decrease at A3. The lack of increase in action scores is
of interest as others have reported that adolescents who received CBT or a combination
of CBT and antidepressants showed larger gains in action scores over those who received
antidepressants alone or pill placebo (Lewis et al., 2009). Our findings did not reveal
reliable improvements in action scores, even for those who received behavior therapy.
Lastly, Cronbach’s alpha .67 and a standard deviation of 2.13 yielded a RCI of 3.39 for
the maintenance subscale of the SOCQ. Two of fourteen (14%) participants showed a
reliable decrease in maintenance scores following MIA while one participant showed a
reliable increase over the follow up period. Although motivational interviewing
techniques were presented during the MIA phase of the study, participant reports of
motivation to change did not consistently improve to achieve the action or maintenance
stages of change. Of note, however, is that those who received FA, 2/4 showed reliable
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increases in contemplation subscale scores following MIA, and again at six week follow
up.
A reliable change criterion was also calculated for participant reports of
therapeutic alliance. Shirk, Gudmundsen, Kaplinski, and McMakin (2008) reported
Cronbach’s alpha for the TASA adolescent reports at .86 and a standard deviation of
8.43. The standard deviation for the current sample was quite similar to that of Shirk et
al. at 8.18. Reliable change calculations yielded a RCI of 8.48. None of the nine
participants who completed the study reported a reliable change in therapeutic alliance at
an assessment point immediately following an active treatment phase, therefore,
therapeutic alliance did not account for changes on dependent measures.
Pearson correlations were conducted to determine the amount of association
between depression scores and activation for the entire sample. As expected, BDI-II
scores were negatively related to activation scores on the BADS-SF at most assessment
points: [A1 = r (14) = -.601, p = .012]; [A2 = r (13) = -.754, p = .001]; [A3 = r (5) = .925, p = .012]; [A4 = r (5) = -.639, p =.123]; and [A5 = r (7) = -.79, p = .017]. Further,
activation was negatively associated with depression on the BADS-SF and CDRS-R,
respectively: [A1 = r (14) = -.525, p = .027]; [A2 = r (13) = -.721, p = .003]; [A3 = r (5)
= -.937, p = .009]; [A4 = r (5) = -.866, p = .029]; and [A5 = r (7) = -.857, p = .071].
These associations provide further support for the behavioral model of depression, which
indicates that depressive symptoms increase as activation decreases.
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Table 3. CDRS-R Scores Across Assessment Times by Responder Status
Participant
A1
A2
A3
A4

A5

MIA
6

49

22*

-

-

25

7

47

30*

-

-

-

8

57

26*

-

-

-

9

57

32*

-

-

23

10

53

26*

-

-

17

52.6 (4.56)

27.2 (3.90)

-

-

21.67 (4.16)

3

59

47*

27*

27

21

5

79

61*

21*

-

22

12

58

41*

21*

25

-

65.33 (11.85)

49.67 (10.26)

23 (3.46)

26 (1.41)

21.5 (.71)

53

67*

52*

31*

25

1

65

44*

56*

-

-

4

49

44

-

35

-

11

72

63

-

-

25

13

66

56

-

52

-

14

59

-

-

-

-

62.2 (8.70)

51.75 (9.39)

56

43.5 (12.02)

25

Mean (SD)
FA

Mean (SD)
VBBA
2
Drop out

Mean (SD)

*Meets RCI criterion during preceding interval
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Table 4. BDI-II Scores Across Assessment Times by Responder Status
Participant
A1
A2
A3
A4

A5

MIA
6

3

0

-

-

0

7

16

13

-

-

-

8

20

5*

-

-

-

9

14

2*

-

-

1

10

11

2*

-

-

1

12.8 (6.38)

4.40 (5.13)

-

-

.67 (.58)

3

24

7*

3

2

1

5

42

30*

5*

-

0

12

16

9

8

9

-

27.33 (13.32)

15.33 (12.74)

5.33 (2.51)

5.5 (4.95)

.5 (.71)

31

26

24

14*

11

1

25

33

24*

-

-

4

19

16

-

25

-

11

44

37

-

-

5

13

16

23

-

12

-

14

13

-

-

-

-

23.4 (12.34)

27.25 (9.54)

24

18.5 (9.19)

5

Mean (SD)
FA

Mean (SD)
VBBA
2
Drop out

Mean (SD)

*Meets RCI criterion during preceding interval
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Table 5. BADS-SF Scores Across Assessment Times by Responder Status
Participant
A1
A2
A3
A4

A5

MIA
6

32

30

-

-

34

7

27

28

-

-

-

8

35

40

-

-

-

9

26

27

-

-

34

10

20

42*

-

-

45

28.00 (5.79)

33.40 (7.06)

-

-

37.67 (6.35)

3

27

33

37┼

40

36

5

16

10

46*

-

49

12

25

27

39*

39

-

22.67 (5.86)

23.33 (11.93)

40.67 (4.73)

39.5 (.71)

42.5 (9.19)

11

15

14

29*

17

1

14

17

22

-

-

4

26

34

-

28

-

11

16

23

-

-

38

13

16

25*

-

23

-

14

26

-

-

-

-

19.6 (5.9)

24.75 (7.04)

22

25.5 (3.54)

38

Mean (SD)
FA

Mean (SD)
VBBA
2
Drop out

Mean (SD)

*Meets RCI criterion during preceding interval, ┼ cumulative change exceeds RCI
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Table 6. HRQOL Scores Across Assessment Times by Responder Status
Participant
A1
A2
A3
A4

A5

MIA
6

0

3

-

-

7

7

10

7

-

-

-

8

7

3

-

-

-

9

7

9

-

-

2

10

15

10

-

-

7

7.8 (5.45)

6.4 (3.29)

-

-

5.33 (2.89)

3

18

5

4

3

2

5

24

15

4

-

0

12

10

8

7

7

-

17.33 (7.02)

9.33 (5.13)

5 (1.73)

5 (2.83)

1 (1.41)

26

27

17

10

5

1

3

20

20

-

-

4

5

2

-

4

-

11

28

4

-

-

5

13

20

18

-

20

-

14

15

-

-

-

-

14.2 (10.43)

11 (9.31)

20

12 (11.31)

5

Mean (SD)
FA

Mean (SD)
VBBA
2
Drop out

Mean (SD)
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Table 7. SOCQ Precontemplation Scores Across Assessment Times by Responder Status
Participant
A1
A2
A3
A4
A5
MIA
6

16

11

-

-

20*

7

16

18

-

-

-

8

11

15

-

-

-

9

20

14*

-

-

16

10

15

18

-

-

17

15.6 (3.21)

15.2 (2.95)

-

-

17.67 (2.08)

3

15

14

18

17

15

5

25

17*

16

-

16

12

14

15

17

14

-

18 (6.08)

15.33 (1.53)

17 (1.0)

15.67 (1.53)

15

11

17*

19

18

20

1

25

23

22

-

-

4

15

14

-

15

-

11

21

19

-

-

23

13

17

17

-

18

-

14

20

-

-

-

-

19.86 (3.85)

18.25 (3.77)

22

16.5 (2.12)

23

Mean (SD)
FA

Mean (SD)
VBBA
2
Drop out

Mean (SD)

*Meets RCI criterion during preceding interval
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Table 8. SOCQ Contemplation Scores Across Assessment Times by Responder Status
Participant
A1
A2
A3
A4
A5
MIA
6

4

8*

-

-

6

7

9

9

-

-

-

8

8

7

-

-

-

9

9

11

-

-

11

10

10

9

-

-

12

8.00 (2.35)

8.8 (1.48)

-

-

9.67 (3.21)

3

8

11

9

10

12

5

4

10*

7

-

14*

12

12

16*

9*

13*

-

8.00 (4.00)

12.33 (3.21)

8.33 (1.15)

12.33 (2.08)

12

10

8

8

7

8

1

4

4

8

-

-

4

12

12

-

11

-

11

11

9

-

-

6

13

10

8

-

8

-

14

8

-

-

-

-

9.00 (3.16)

8.25 (3.30)

8

9.5 (2.12)

6

Mean (SD)
FA

Mean (SD)
VBBA
2
Drop out

Mean (SD)

*Meets RCI criterion during preceding interval
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Table 9. SOCQ Action Scores Across Assessment Times by Responder Status
Participant
A1
A2
A3
A4

A5

MIA
6

6

5

-

-

20

7

10

14

-

-

-

8

18

12*

-

-

-

9

16

11*

-

-

16

10

17

10*

-

-

17

13.4 (5.18)

10.4 (3.36)

-

-

17.67 (2.08)

3

16

14

11

9

15

5

16

12

7*

-

6

12

15

15

12

15

-

15.67 (.58)

13.67 (1.53)

10 (2.65)

10 (4.58)

15

11

11

10

10

10

1

9

5

8

-

-

4

15

12

-

11

-

11

13

10

-

-

17

13

16

17

-

9

-

14

17

-

-

-

-

14 (3.16)

11 (4.97)

8

10 (1.41)

17

Mean (SD)
FA

Mean (SD)
VBBA
2
Drop out

Mean (SD)

*Meets RCI criterion during preceding interval
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Table 10. SOCQ Maintenance Scores Across Assessment Times by Responder Status
Participant
A1
A2
A3
A4
A5
MIA
6

10

8

-

-

13*

7

11

12

-

-

-

8

13

11

-

-

-

9

13

12

-

-

15

10

10

13

-

-

16

11.4 (1.52)

11.2 (1.92)

-

-

14.67 (1.53)

3

10

11

14

13

12

5

13

8*

14

-

15

12

13

9*

16

14

-

12 (1.73)

9.33 (1.53)

14.67 (1.15)

14 (1.0)

12

8

9

12

10

11

1

13

13

10

-

-

4

12

12

-

16

-

11

15

15

-

-

17

13

12

12

-

13

-

14

16

-

-

-

-

13.6 (1.62)

13 (1.41)

10

14.5 (2.12)

17

Mean (SD)
FA

Mean (SD)
VBBA
2
Drop out

Mean (SD)

*Meets RCI criterion during preceding interval
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Table 11. TASA Participant Scores Across Assessment Times by Responder Status
Participant
A2
A3
A4
A5
MIA
6

71

-

-

72

7

54

-

-

-

8

66

-

-

-

9

62

-

-

66

10

72

-

-

67

65 (7.35)

-

-

68.33 (3.22)

3

61

64

66

72

5

71

72

-

72

12

54

49

59*

-

62 (8.54)

61.67 (11.68)

62.5 (4.95)

72

70

72

65

71

1

71

56*

-

-

4

49

63*

-

-

11

56

-

-

69

13

55

-

45

-

14

-

-

-

-

57.75 (9.36)

59.5 (4.95)

45

69

Mean (SD)
FA

Mean (SD)
VBBA
2
Drop out

Mean (SD)

*Meets RCI criterion during preceding interval
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When participants were stepped out or chose to discontinue treatment, follow up
data were collected whenever possible at the subsequent assessment points to assess
maintenance. Follow up data from at least one time point was available for 11/14 (79%)
participants. Those for whom there is no follow up data were two MIA responders and
one who dropped out of MIA. As a reminder, the time interval between A1 and A2 was
four weeks, A2-A3 was six weeks, A3-A4 was six weeks, and A4-A5 was four weeks.
Maintenance data from the CDRS-R, BDI-II, and BADS-SF were emphasized because of
their clinical and theoretical relevance. All participants who had a clinically significant
change on the CDRS-R (and for whom follow up data were available) showed
maintenance of their depression symptom change at follow up: 3/3 at 16 weeks postMIA, 3/3 at six weeks (P3 and P12) or 10 weeks (P3 and P5) post-FA, and 1/1 at 4 weeks
post-VBBA. The BDI-II data also suggest maintenance of gains for all seven participants.
Among those who discontinued participation, 2/4 (P1 and P13) continued to meet the
CDRS-R inclusion criterion at follow up, whereas 2/4 (P4 and P11) did not. The BDI-II
also suggests decreased depression at follow up for 2/4 (P11 and P13) participants, but
not the other 2/4 (P1 and P4; however, the CDRS-R and BDI-II data only agree on P1
and P11). In sum, the follow up depression data are consistent with the idea that those
treated to when clinically significant change was achieved maintained improvement
while follow up was more variable for those who discontinued treatment.
With respect to the BADS-SF, only one (20%) MIA responder (P10) met the RCI
and increased activation was maintained 16 weeks later. For the remaining two MIA
responders for whom follow up data was available (P6 and P9), no reliable change in
activation was observed over the follow up interval. For the 3/3 responding to FA,
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increased activation was maintained at follow up assessments at six weeks for P12, 10
weeks for P5, and six and 10 weeks for P3 (remembering that P3 only reached the
BADS-SF RCI criterion cumulatively over the A1-A3 interval). For P2, the responder to
VBBA, the increased activation was lost at four week follow up.
Mediator Analyses
Mediator analyses were conducted for participants 2, 3, 5, and 12 as these
participants had clinically significant responses during the FA or VBBA treatment
intervals and thus are candidates for closer examination of the time course of change
during treatment. Gaynor and Harris (2008) identified four components necessary for the
analysis of mediators in single-participant studies. The first component involves
identifying if the participant received treatment. Second, it must be demonstrated that the
participant experienced improvement during the time frame that the treatment was
received. Next, assessment scores must indicate that there was a positive change in the
proposed mechanism of action. Finally, a change on the proposed mechanism of action
must precede a significant amount of symptom improvement. These components of
mediator analysis are discussed below for the four participants who exhibited a
significant response via CDRS-R scores following FA or VBBA.
For the current study, the receipt of treatment was determined first by identifying
the percentage of sessions attended out of the number of sessions offered, relative to the
final phase that the participant was invited to enter. Second, as previously mentioned,
therapist adherence was excellent across treatment phases, indicating that the therapist
did adhere to the treatment protocol as specified and therapist ratings on the main
dependent measure showed excellent reliability.
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Clinical improvement at the major assessment points was determined using the
CDRS-R and BDI-II scores as described above. As activation is the proposed mechanism
of action and outcome was measured by scores on depression measures, the BDI-SF and
BADS-SF were given at each session (and assessment) as repeated measures. Using
internal consistency data (α = .92) on the BDI-II with adolescents (Steer, Kumar, Ranieri,
& Beck, 1998) and a pretreatment SD from the current samples (M = 12.71, SD = 7.36)
the RCI for BDI-SF was calculated to be 5.77. As described above, the RCI cutoff for the
BADS-SF was > 8.44.
In order to determine the direction of change on depression symptoms and
activation, ipsative z scores were calculated with regard to the BDI-SF and BADS-SF
repeated measures. These scores are calculated by subtracting the participant’s session
score from that participant’s mean score, then dividing by the participant’s standard
deviation on the measure (Meuser, Yarnold, & Foy, 1991; Gaynor & Harris, 2008). The
resulting sign of the z score is the indicator of whether the score for the assessment point
is higher or lower than average for that participant. Scores indicative of clinical
worsening were coded as “0” while those indicative of clinical improvement were coded
as “1.”
Participant 3. P3 was an 18-year old Caucasian male in 12th grade at the time of
the study. This participant lived in a single-parent home with one younger sibling. His
mother completed the demographic questionnaire upon initial assessment and reported a
household income in the range of $25,000 – 34,999. His mother also reported that she
had a history of depression and anxiety, the biological father had a history of substance
abuse, and a grandparent had completed suicide. At initial assessment, the CDRS-R score
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for P3 was 57, placing him above the 95th percentile for depression severity. The BDI-II
score for this participant at A1 was 24, which is indicative of severe depression (Roberts
et al., 1991). P3 attended 3/3 MIA sessions and 4/4 FA sessions offered, suggesting that
at least to some extent, treatment was received.
The data from the assessment sessions suggest P3 had a reliable change on the
CDRS-R following MIA (CDRS-R = 47), but only showed a clinically significant change
following FA based on a CDRS-R score of 27 at A3. The BDI-SF showed reliable change
during MIA to a low level, while the BADS-SF showed gradual change only reaching the
RCI at the conclusion of FA. Thus, these were indicators of both significant changes in
depression and activation, the latter being the proposed mediator, in the assessment data.
No reliable changes were noted on the SOCQ or TASA for P3.
Repeated measures data were collected on a session-by-session basis to examine
the time course of change. Figure 2 shows BDI-SF and BADS-SF repeated measure
scores for P3. As shown in the figure, a reliable change in depression scores occurred
prior to receipt of MIA session 2 (as indicated by open markers). The reliable change in
activation was observed prior to FA session 1. The RCI data suggest that for this
participant the vast majority of change in depression preceded the increase in activation,
and that both occurred before receipt of FA.
The ipsative z score data result in similar conclusions. The session in which the
individual BDI-SF score was first lower than P3’s average BDI-SF score across the
course of participation was the 3rd MIA session. The first individual BADS-SF to exceed
the overall average occurred later, prior to the initial FA session. Thus, the repeated
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measures data for P3 are not consistent with the proposed model of change where FA
increased activation which decreased depressive symptoms.
In sum, the combined assessment and repeated measure data for P3 suggest
cumulative changes in both depression and activation over the course of the MIA and FA
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Figure 2. Repeated Measures for Participant 3

Participant 5. P5 was a 17 year-old multiracial female in 12th grade at the time of
the study. She lived in a single-parent home with her mother and no siblings and had a
reported household income of $10,000 – 14,999. Family history of mental health
indicated that the participant’s mother had a history of depression, anxiety, and
suicidality while her father had been convicted of a felony. At A1, this participant’s
CDRS-R score was 79, placing her in the 99th percentile for depressive symptomatology.
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Her BDI-II score was 42, indicating severe depression. P5 attended 5/7 (71%) of
available treatment sessions (2/3 MIA and 3/4 FA sessions offered).
The CDRS-R score for P5 showed a reliable change from A1 to A2 from 79 to 61,
respectively. The CDRS-R did not show clinically significant change until A3, with a
score of 21. Similarly, the BDI-II decreased to a score of 30 at A2 but showed its largest
decrease after FA at A3 to a score of 5. The BADS-SF data are especially interesting as
there was no reliable change from A1 to A2 but a large increase was observed at A3.
Thus, these data suggest the most substantial changes in both depressive symptoms and
activation occurred in the time frame when FA was provided. Therapeutic alliance did
not change during this interval.
Figure 3 shows BDI-SF and BADS-SF repeated measure scores for P5. The BDISF scores for this participant show two reliable changes occurring before FA. Even with
the substantial change in depression prior to FA, The BDI-SF score of 10 was only
slightly above the recommended cut score of 9 when FA began. Two reliable changes on
the BADS-SF were observed, one in FA session 2 and the other at the conclusion of FA
at A3. The first reliable change in activation (which was followed by continued increases)
preceded a subsequent reliable change on the BDI-SF to a level well below the
recommended cutoff for detecting depression. BDI-SF ipsative z scores for P5 indicated
that the first BDI-SF score that was below the series average occurred at FA session 1,
prior to the receipt of FA. All subsequent administrations of the BDI-SF were also coded
as 1. BADS-SF ipsative z scores prior to FA were not above the series average; however,
beginning with FA session 2, and all subsequent sessions and assessment points the
BADS-SF scores exceeded the series mean and were coded as 1.
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The combined assessment and repeated measures data for P5 suggest that
increased activation was uniquely associated with FA. Depressive symptoms began a
decreasing trajectory during MIA that did not reach clinical significance until FA. The
ultimate achievement of clinically significant change in depressive symptoms was
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Figure 3. Repeated Measures for Participant 5

Participant 12. Participant 12 was a 15 year-old multiracial 9th grade male. He
resided in a single-parent home with his father and brother at the time of the study. His
father reported a household income of $50,000 – 74,999. This participant had an uncle
with a history of schizophrenia and mental health hospitalizations. At baseline,
Participant 12’s CDRS-R score was 58, placing him above the 95th percentile with regard
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to depression severity and his BDI-II score was 16, indicative of moderate depression.
P12 attended 5/7 (71%) of therapy sessions offered, including 1/3 MIA and 4/4 FA.
A reliable but not clinically significant change was noted on the CDRS-R from
A1 to A2. The BDI-II and BADS-SF did not meet the RCI during this interval. However,
during the time in which FA was offered, the CDRS-R showed a second reliable change
that resulted in meeting criteria for clinically significant change. Likewise, the BADS-SF
showed a reliable increase by A3. The scores on the TASA suggest no reliable change in
therapeutic alliance.
The BDI-SF and BADS-SF repeated measures for Participant 12 are shown in
Figure 4. On the BDI-SF, there was no reliable change; however, activation scores
exhibit a reliable change at FA session 2 and at A3. During FA, a divergent pattern
between activation and depression clearly appears. A decrease in depression scores was
observed during the first phase of treatment, which occurred at A2 but was not
maintained (see Figure 4). Likewise, a change on the BADS-SF that nearly exceeded the
series mean was noted at MIA session 1, but did not predict persisting change. However,
the BADS-SF score to exceed the mean was in FA session 2 and three of the subsequent
four BADS-SF scores were positive. The positive BADS-SF change in FA session 2
preceded change on the BDI-SF where positive ipsative z scores were not obtained until
FA session 4 and A3. The combined assessment and repeated measures data for P12
indicate at a minimum a cross-sectional negative relationship between activation and
depression with a hint that activation change may have preceded depression symptom
change making activation a plausible mediator.
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Figure 4. Repeated Measures for Participant 12

Participant 2. P2 was a 17 year-old Caucasian female in 11th grade at the time of
the study. The participant resided with her mother, step-father, and four siblings in a rural
community. At the time of initial assessment, the participant’s mother reported her own
history of depression, anxiety, and an eating disorder. Family income was not reported by
the caregiver for this participant, although both the mother and step-father worked
outside of the home. The CDRS-R score for this participant was 53 at baseline placing
her above the 95th percentile for depressive symptomatology. Her BDI-II score was 31,
indicating severe depression. P2 attended 9/11 (82%) therapy sessions, 3/3 MIA, 3/4 FA,
and 3/4 VBBA.
P2’s CDRS-R scores showed a reliable worsening from A1 to A2 followed by a
reliable improvement from A2 to A3 that marked a return to pretreatment levels. From
A3 to A4 a reliable change to a score indicative of clinically significant improvement was
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observed on the CDRS-R. The BDI-II remained high across A1, A2, and A3 showing a
reliable change at A4, while the BADS-SF was low across A1, A2, and A3 showing a
reliable change only at A4. Thus the significant changes in depression and activation that
were observed occurred during the interval in which VBBA was received. No reliable
change on the TASA was observed from A2 to A3 or A3 to A4.
BDI-SF and BADS-SF repeated measures for Participant 2 are shown in Figure 5.
Both depression and activation scores are quite variable during the first phase. The BDISF shows reliable change at MIA session 1 that is lost at MIA session 2 and regained at
MIA 3. Similarly the BADS-SF met the RCI at MIA 3 but it was lost by A2. Thus, P2
entered FA with a BDI-SF score about the suggested cutoff of 9 and without a persisting
change in activation. Neither the BDI-SF nor BADS-SF met the RCI during FA.
However, reliable change in activation became apparent at VBBA session 2 which
preceded the reliable change BDI-SF at VBBA session 4. Figure 5 also provides the BDISF and BADS-SF ipsative z scores for P2. The interval from A1 through FA1 showed the
fluctuating of improvement and return to pretreatment levels of both depression and
activation scores. Improvements on repeated measures were observed just prior to VBBA
session 1, which were maintained across the course of VBBA.
The combined assessment and repeated measures data suggest that significant and
persistent changes in depression symptoms and activation occurred during VBBA and
that reliable changes in activation preceded a persisting reliable change in depression
such that activation appears to be a plausible mediator for P2.
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DISCUSSION
The purpose of the current study was to further evaluate the utility of a steppedcare approach to the treatment of adolescent depression utilizing motivational
interviewing assessment, fun activities, and values-based behavioral activation as less to
more invasive steps of treatment. Motivational interviewing and behavioral activation are
empirically supported treatments that are relevant across a wide range of populations.
While a values-based approach to behavioral activation has been recommended (Lejuez
et al., 2011), little is known of the utility of this approach over assigning enjoyable
activities during behavioral activation. Subsequent to findings by Gaynor and Harris
(2008) indicating the receipt of VBBA as a possible mediator for increased activation,
which may have mediated decreased depression scores, the present study sought to
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determine the utility of presenting VBBA to those participants who did not experience a
clinically significant change on depression scores following the receipt of FA.
Results of the current study clearly support a stepped-care model for the treatment
of adolescent depression. The MIA approach allowed the therapist to conduct the MINIKID assessment interview over three sessions in combination with motivational
interviewing strategies in an effort to increase motivation for change. During the interval
from A1-A2, 12/14 (86%) participants showed a numerical decrease in depressive
symptoms on the CDRS-R. This change was a reliable improvement for 9/12 (75%)
participants. Participants who experienced a clinically significant change immediately
following the MIA phase of treatment were observed at pretreatment to have lower scores
on depression measures and higher levels of activation than those who responded to
behavior therapy or those who withdrew from the study. Further, therapeutic alliance was
not able to account for differences in outcome for this group (see below). These findings
are consistent with behavioral models of depression indicating that depression may be
functionally related to avoidance (Ferster, 1973) or low rates of reinforcement for
activities in which the individual engages (Lewinsohn & Graf, 1973) but that, for those
who experienced a clinically significant change during MIA, activation was within the
individual’s repertoire and motivation to engage the repertoire may have increased during
the MIA phase of the study. The stepped-care model requires the application of the least
invasive treatments as the first treatment approach. Therefore, MIA can be considered a
reasonable first step in treating depressed adolescents.
Behavioral activation, the proposed mechanism of change, was observed to be a
reasonable, partial, or plausible mediator in the current study. As mentioned above, it
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appears that those who experienced a clinically significant change during MIA may have
experienced increased motivation to engage an existing activation repertoire during the
initial phase of the study. For those receiving behavior therapy (either FA or VBBA),
activation increased and depressive symptoms decreased during the phase in which those
participants experienced a clinically significant change. This finding is consistent with
that of Gaynor and Harris (2009) in which 3/4 participants who received VBBA
experienced increased activation, and, for 2/4 activation was a reasonable mediator. The
current study replicated this finding as activation was determined to be a potential
mediator for 3/4 who received behavior therapy. Additionally, 4/4 participants in the
current study who received behavior therapy experienced an increase in activation.
Pooling the Gaynor and Harris (2009) data with the data from the current study, for 5075% of adolescents who received behavior therapy, activation appears to mediate
depressive symptoms.
Fourteen participants were enrolled and nine (64%) completed the study. All
participants who completed the study experienced a clinically significant change in
depression scores. Therapeutic alliance was not found to be a plausible mediator for any
of the participants. This finding was not due to poor therapeutic alliance; rather, the A2
TASA average of 62.46 (8.18) is quite similar to a normative sample of depressed
adolescents reported by Shirk et al. (2008) to be M = 62.07 (8.43). While the alliance data
of the current study appear to represent that reported in Shirk et al. (2008), A2 TASA
scores in the present study were not correlated with A2 depression scores
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(n = 13, r = -.115, p = .709), while those in the normative sample did. In sum, MIA may
create effective alliance and change, but alliance is not a mediator for depressive
symptoms, even within the MIA phase.
Baseline depression scores of participants in the current study are also comparable
to those of TADS (2004), which is, to date, the largest empirical evaluation of treatment
for adolescent depression. The sample used in the TADS study was found to have an
average CDRS-R score of 60 (10.4) at pretreatment, and the current study participants
had an average score of 58.79 (9.11). Ages and grades of the current sample were also
comparable to that of the TADS study. The present study enrolled a diverse sample of
participants: 42.9% of the sample identified as African American, 28.6% as EuroAmerican, 14.3% as Latino, and 14.3% as Biracial. A total of 71% (n = 10) of the sample
identified as belonging to a racial minority group. Half of the participants were reported
to live in a single-parent home, and 50% were reported to have a household income at or
near the Federal Poverty Guidelines (United States Department of Health and Human
Services, 2012). The demographic data for the current study is more diverse than that
reported in TADS (2005) in which the authors reported that 73.8% of the sample was
white and 61% reported a household income > $40,000. As reported by the TADS team
(2006) income level was a significant moderator for outcomes on depression. For the
total sample in their study, combination treatment (both antidepressant and CBT) was
found to perform better than CBT alone. However, for those participants with higher
household incomes (≥ $75,000), combination treatment and CBT alone both performed
better than placebo. The current study was much more diverse in terms of race and
income than that reported in TADS. Present results indicate that MIA and behavior
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therapy can be effective in the treatment of depression for a racially diverse group of
adolescents from low income households. Jacob, Keeley, Ritschel, and Craighead (2013)
also recently reported outcomes for behavioral activation with depressed, low-income,
African American adolescents. The authors indicated that outcomes with this population
had not previously been published and that they found the treatment to be effective in
decreasing symptoms of depression for 2/3 participants. Data from the current study
support these findings and contribute to our knowledge of the effectiveness of behavioral
activation among a racially diverse, low-income sample.
Another point of divergence from previous outcome studies related to adolescent
depression is that therapy sessions for the current study took place at two Midwestern
high schools. Shirk, Kaplinski, and Gudmundsen (2009) found school-based CBT for
depressed adolescents to be effective in decreasing depressive symptoms for 64% of the
sample. Data from the current study support these findings as 64% (n = 9) of the current
sample experienced a clinically significant change during treatment. The present study
provides further support for behavioral activation within a school setting.
There are several limitations to the current study. First, the study therapist
conducted all assessments and was aware of the progression of each participant through
study phases. While independent assessors are typically a requirement in clinical outcome
research involving the efficacy of proposed treatments, within clinical settings including
mental health clinics, schools, and private practices, therapists are often those
administering and interpreting assessments. Second, attrition reached 36% (n = 5). Given
the small sample size, many group-level statistics were not able to be conducted. While
single-participant meditational analyses were conducted, some may argue that conclusive
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causal statements cannot be made regarding the relationship between activation and
depressive symptoms. Further, while participants were informed during the consent
process and were reminded of ongoing assessments throughout the study, several
assessment times were not attended by participants, particularly MIA responders and
those who withdrew from the study. Third, protocols for FA and VBBA were noticeably
different in the approach to activation. However, it is possible that some fun activities
may also be values-consistent activities. For example, P12 enjoyed specific activities
with his parent and sibling and increased his participation in such activities during the FA
phase. It is possible that these types of activities also activated a value involving family
relationships or health-related activities. Since values were not assessed during the FA
phase of the study, it is unknown if participants who increased fun activities also
increased values-based activities.
In sum, the current study provides support for the utility of a stepped-care
approach to adolescent depression using motivational interviewing assessment as the first
and least invasive step and fun activities and values-based behavioral activation as
increasing levels of care, respectively. Sixty-four percent of the sample experienced a
clinically significant improvement in depression scores during treatment. While 36% of
the sample experienced clinically significant change during the MIA phase of treatment,
those participants were significantly less depressed and more activated at pretreatment
than were other participants. Four participants entered and experienced a clinically
significant response to behavior therapy (either FA or VBBA). For 3/4 who received
behavior therapy, activation was found to be a potential mediator for clinically significant
change on depression scores. Based on SOCQ scores, motivational interviewing

65

assessment did not alter participant motivation for treatment; however, it is possible that
the measure did not capture participant’s experience of increased motivation for change.
Therapeutic alliance was also not able to account for changes on outcome measures. This
study also provides further support for the use of a stepped-care model with a diverse
sample of adolescents in a school-based setting.
Future research should endeavor to further evaluate the usefulness of motivational
interviewing as a strategy to improve motivation and the utility of stages of change to
predict the appropriate first step for treatment among depressed adolescents. Although the
current study contributes to our knowledge of stepped-care approaches, behavioral
activation, and treatment of low-income, racially diverse, depressed adolescents in a
school-based setting, the small sample size requires that data continue to be collected in
order to draw more firm conclusions about the effectiveness of the approach with this
population.
This research was supported by the Western Michigan University Alliances for
Graduate Education and the Professoriate.
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